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We have shown that the destabilization of HIF1␣ upon inhibition of mitochondrial respiration in hypoxia is dependent on prolyl hydroxylase activity. Because inactivation of prolyl hydroxylases in hypoxia is a result of limited O 2 availability, we reasoned that respiratory inhibitors might increase the availability of nonrespiratory O 2 and consequently reactivate the enzymes. The experiments with Renilla luciferase indicate that inhibition of mitochondrial respiration can indeed increase cellular O 2 availability. This increase would be significant in hypoxia when the cellular O 2 concentration becomes limiting for enzymes such as prolyl hydroxylases, which have a higher K m for O 2 than does cytochrome c oxidase (21, 22) . Our results suggest that NO acts as an endogenous regulator of intracellular O 2 availability in mammalian cells (23, 24) . Supporting the physiological relevance of the NO-dependent increase in O 2 availability is a study showing that bioluminescence in fireflies is dependent on NO release (25) .
We have recently discussed metabolic hypoxia, a pathophysiological state in which, although O 2 is present, its use in mitochondrial respiration is prevented by occupation of cytochrome c oxidase by NO (23) . We now demonstrate that inhibition of mitochondrial O 2 consumption creates the paradox of increased O 2 availability for prolyl hydroxylation of HIF1␣, leading to a situation in which the cell may fail to register hypoxia. It is possible that NO-dependent diversion of O 2 may reactivate other enzymes whose activities are reduced in hypoxia. The physiological and pathological implications of these observations remain to be investigated. Aberrant expansion of microsatellites is associated with a number of neurological diseases (1) (2) (3) (4) . Myotonic dystrophy (dystrophia myotonica, DM) is often characterized by myotonia, or delayed muscle relaxation due to repetitive action potentials in myofibers, and muscle de- generation (3) . Manifestations of DM may also include heart block, ocular cataracts, hypogonadism, and nervous system dysfunction. DM type 1 (DM1) is caused by a (CTG) n expansion (n ϭ 50 to Ͼ3000) in the 3Ј-untranslated region (3ЈUTR) of the DMPK gene, whereas DM type 2 (DM2) is caused by a (CCTG) n expansion (n ϭ 75 to ϳ11,000) in the first intron of ZNF9 (4, 5) . How does the expansion of noncoding CTG or CCTG repeats result in dominantly inherited neuromuscular disease? Both DM1 and DM2 mutant transcripts accumulate in foci within muscle nuclei (5-10).
An indication that these transcripts are pathogenic comes from studies on HSA LR mice that express a large CTG repeat in the 3ЈUTR of a human skeletal actin transgene (9) . These transgenic mice develop myonuclear RNA foci, myotonia, and degenerative muscle changes similar to those seen in human DM. The myotonia in HSA LR mice is caused by loss of skeletal muscle chloride (ClC-1) channels due to aberrant pre-mRNA splicing (11, 12) . Similar ClC-1 splicing defects exist in DM1 and DM2. However, the connection between accumulation of mutant DM transcripts in the nucleus and altered splice site selection has not been established (11) (12) (13) (14) (15) .
Proteins in the MBNL (muscleblind-like) family bind to expanded CUG repeats in vitro and colocalize with mutant DM and HSA LR transcripts in vivo (8 -10, 16, 17) . Human muscleblind genes MBNL1, MBNL2, and MBNL3 are homologous to the Drosophila gene muscleblind, which is essential for muscle and eye differentiation (8, 18, 19) . MBNL1, the major MBNL gene expressed in human skeletal muscle, encodes multiple protein isoforms, including some that bind to expanded CUG repeats (41 to 42 kD) and others that fail to bind (31-kD isoform generated by exon 3 skipping) ( fig. S1) (8, 17) . Expression of CUG and CCUG expansion RNAs induces MBNL recruitment into nuclear RNA foci, but there is no evidence that this relocalization results in muscleblind depletion and functional impairment (8 -10, 20) .
To test the hypothesis that sequestration of MBNL proteins contributes to DM pathogenesis, we generated mice with a targeted deletion of Mbnl1 exon 3 (E3) (Fig. 1A) (21) . We postulated that this targeting strategy would approximate the situation in DM by eliminating synthesis of CUG-binding isoforms (8) . Genomic blot analysis demonstrated successful deletion of Mbnl1 E3 in Mbnl1 ⌬E3/⌬E3 mice (Fig. 1B) . Loss of E3 expression was confirmed by reverse transcription polymerase chain reaction (RT-PCR); primers in exons 3 and 6 amplified a cDNA product from either Mbnl1
ϩ/⌬E3 mice that was absent in Mbnl1 ⌬E3/⌬E3 mice (Fig. 1C) . As expected, Mbnl1 expression was not fully eliminated in Mbnl1 ⌬E3/⌬E3 mice; RT-PCR products were apparent with primers in constitutively spliced exons 10 and 12, or within exon 13. To confirm elimination of the Mbnl1 41-to 42-kD proteins in Mbnl1
⌬E3/⌬E3 mice, we used monoclonal antibody 3A4, which recognizes Mbnl1 proteins containing exon 5 (20) (fig. S1) (Fig. 1D) . Previous studies have suggested that elevated levels of another RNA-binding protein, CUGBP1, are responsible for DM-associated RNA splicing changes (13) (14) (15) . However, Mbnl1 ⌬E3/⌬E3 mice did not show increased Cugbp1 expression (Fig. 1D) . Mbnl1 ⌬E3/⌬E3 mice display overt myotonia beginning around 6 weeks of age. Delayed muscle relaxation was most noticeable after a period of rest and showed improvement during activity (movie S1). A similar "warm up" phenomenon is characteristic of myotonia in human DM. Electromyographic recordings confirmed myotonic discharges in all Mbnl1 ⌬E3/⌬E3 mice tested (n ϭ 10) ( Fig.  2A) . Because myotonia in DM1 and DM2 muscle is associated with aberrant ClC-1 splicing (11, 12), we used RT-PCR assays to investigate the effect of loss of Mbnl1 E3 on ClC-1 (encoded by Clcn1) expression (Fig.  2B) . Remarkably, Mbnl1 ⌬E3/⌬E3 mice showed abnormal inclusion of Clcn1 cryptic exons 7a and 8a in a pattern similar to that seen in HSA LR mice. Also, some full-length ClC-1 cDNA clones from Mbnl1 ⌬E3/⌬E3 mice showed abnormal inclusion of intron 2 (21), as has been observed in DM and HSA LR muscle (11, 12) . Notably, these abnormal splice isoforms have premature termination codons and do not encode functional chloride channels (11) . By contrast, splicing of the Scn4a sodium channel, the only other ion channel previously associated with myotonia, was normal in Mbnl1
muscle (21) . These results suggested that changes in splice site selection result in the loss of functional ClC-1 from myofiber membranes. Immunofluorescence analysis confirmed a major reduction of ClC-1 protein in Mbnl1 ⌬E3/⌬E3 muscle relative to the muscle of wild-type sibs (Fig. 2, C and D) , whereas the membrane-associated proteins dystrophin (Fig. 2, E and F) and ␣-sarcoglycan (fig. S2) were unaffected. Because abnormalities of ClC-1 splicing in Mbnl1 ⌬E3/⌬E3 muscle are more pronounced than in HSA LR muscle, and considering that HSA LR mice have a Ͼ80% reduction of chloride conductance (11), it is likely that myotonia in Mbnl1 ⌬E3/⌬E3 mice is due to improper ClC-1 pre-mRNA splicing.
Histological analysis of Mbnl1
mice up to 11 weeks of age did not show major degeneration of muscle fibers. Pathological features in Mbnl1 ⌬E3/⌬E3 muscle included an increase in nuclei with an abnormal (central) position and splitting of myofibers (Fig. 2, G and H) . Histologic abnormalities were not observed in Mbnl1 ϩ/ϩ or Mbnl1 ϩ/⌬E3 muscle. Besides muscle abnormalities, distinctive ocular cataracts that progress from subcapsular "dust-like" opacities to mature cataracts are a prominent DM-associated feature (3, 4) . Similar cataracts were observed in all Mbnl1 ⌬E3/⌬E3 eyes examined (n ϭ 24; 3 to 8 months old) but not in wild-type siblings (Fig. 2, I to L).
Abnormal regulation of alternative splicing has been observed in DM1 muscle for cardiac troponin T ( TNNT2), insulin receptor (INSR), and ClC-1 (13) (14) (15) . Of these, analysis of INSR is uninformative because human patterns of INSR alternative splicing are not conserved in mice (22) . However,
Mbnl1
⌬E3/⌬E3 adult heart shows abnormal retention of the Tnnt2 "fetal" exon 5 (Fig. 3A) , as was observed for DM1 (13) . To determine whether alternative splicing of other genes is disrupted in Mbnl1 ⌬E3/⌬E3 , we assessed fast skeletal muscle troponin T ( Tnnt3). Primers in Tnnt3 exons 2 and 11 produced a single major RT-PCR product in adult Mbnl1 ϩ/ϩ and Mbnl1 ϩ/⌬E3 mice that was undetectable in Mbnl1 ⌬E3/⌬E3 mice (Fig. 3B) . Instead, a cluster of larger cDNAs, all containing a "fetal" (F) exon (23), was prominent. In contrast, mutually exclusive splicing of Tnnt3 exons 16 and 17 was unaffected in Mbnl1 ⌬E3/⌬E3 mice; this finding shows that altered Mbnl1 expression has specific effects on splice site selection even within the same pre-mRNA (Fig. 3C ). Subsequently, we found similar alterations of TNNT3 splicing in adult DM1 muscle (Fig. 3D) .
These studies confirm a key prediction of the MBNL protein sequestration hypothesis for DM pathogenesis (8) . Loss of specific Mbnl1 isoforms that associate with expanded (CUG) n and (CCUG) n RNAs is sufficient to cause myotonia, cataracts, and RNA splicing defects that are similar to those seen in DM. Although muscleblindlike proteins may influence gene expression at multiple levels, our results raise the possibility that these proteins play a direct role in splice site selection. Indeed, recent studies confirm that MBNL proteins bind to distinct RNA sequence elements and influence exon use during splicing (24) .
Young Mbnl1 ⌬E3/⌬E3 mice do not develop the severe neonatal muscle weakness associated with congenital DM1, and we do not yet know whether cardiac conduction problems develop in this model. Thus, some aspects of the DM phenotype may not result from loss of MBNL1 function alone. Additional muscleblind proteins (MBNL2 and MBNL3) are also recruited to nuclear RNA foci (17) , so their sequestration may be required to fully replicate the multisystemic DM phenotype. Alternatively, other effects of the repeat expansion mutation on gene expression may be required for the full range of disease manifestations (3, 4, 25, 26 
